[Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology*; D003327:Coronary Disease / Q000503:physiopathology*; D005080:Exercise Test; D006321:Heart / Q000187:drug effects; D006801:Humans; D010096:Oxprenolol / Q000494:pharmacology; D005082:Physical Exertion / Q000187:drug effects; D010869:Pindolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D010096:Oxprenolol; D011433:Propranolol; D010869:Pindolol
Zmiany tolerancji wysiłku u osób z choroba wieńcowa po zastosowaniu 4 leków beta-adrenolitycznych (propranolol, visken, oksyprenolol, praktolol.